Project Number 5P01AG017216-09 Agency/Funding Organization NIA Funding Year 2008 View Full Project Details for PHOSPHORYLATION AS A PATHOGENIC MECHANISM IN TAUOPATHY AND AD Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau b. Tau Phosphorylation, Metabolism, and Assembly Researcher and Organization Principal Investigator DUFF, KAREN E Principal Investigator First Name KAREN E Principal Investigator Last Name DUFF Awardee Organization MAYO CLINIC JACKSONVILLE Awardee State Florida Contact PI Country United States Project Detail FY Overall Cost $319,732 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MILLER, MARILYN Related Resources Repository [NIAGADS] Progressive Supranuclear Palsy (PSP) GWAS [NIAGADS] Mayo GWAS [AlzPED] Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. [AlzPED] Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice
